Cargando…
The transcriptional coregulator NAB2 is a target gene for the Wilms' tumor gene 1 protein (WT1) in leukemic cells
The Wilms’ tumor gene 1 (WT1) is recurrently mutated in acute myeloid leukemia. Mutations and high expression of WT1 associate with a poor prognosis. In mice, WT1 cooperates with the RUNX1/RUNX1T1 (AML1/ETO) fusion gene in the induction of acute leukemia, further emphasizing a role for WT1 in leukem...
Autores principales: | Nilsson, Helena Jernmark, Montano, Giorgia, Ullmark, Tove, Lennartsson, Andreas, Drott, Kristina, Järvstråt, Linnea, Nilsson, Björn, Vidovic, Karina, Gullberg, Urban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675621/ https://www.ncbi.nlm.nih.gov/pubmed/29152069 http://dx.doi.org/10.18632/oncotarget.19896 |
Ejemplares similares
-
The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation
por: Sandén, Carl, et al.
Publicado: (2014) -
The Wilms’ tumor (WT1) gene: Methods and protocols
por: Agrawal, Suraksha
Publicado: (2018) -
Wilms’ Tumour gene 1 (WT1) as an immunotherapeutic target
por: Coosemans, A.
Publicado: (2011) -
WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene
por: Montano, Giorgia, et al.
Publicado: (2015) -
Essential genes shape cancer genomes through linear limitation of homozygous deletions
por: Pertesi, Maroulio, et al.
Publicado: (2019)